Halda Therapeutics

Drug DiscoveryWebsite
Current Valuation
$3.0B
As of November 17, 2025
Total Funding Raised
$227.1M
Across 1 round
Last Round
Merger/Acquisition

$3.0B

Last Funding
Nov 2025

Funding date

Capital Efficiency
13.43x

Valuation / Funding

Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
DateRoundAmountPost-ValuationGrowth
July 31, 2024Later Stage VC (Series B)$126.5MN/A-
Valuation Analysis

Current Valuation Metrics

Halda Therapeutics is currently valued at $3.0B as of November 17, 2025. The company has raised a total of $227.1M in funding across 1 funding round.

Capital Efficiency

With a capital efficiency ratio of 13.43x, Halda Therapeutics has achieved a valuation that is 13.43 times the total capital raised.

Track Halda Therapeutics Valuation Updates

Get notified when Halda Therapeutics raises new funding or valuation changes

Explore More Data
Detailed analysis for Halda Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Halda Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Halda Therapeutics Worth in 2026?

Halda Therapeutics is a leading private company in the Drug Discovery sector. Track Halda Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Halda Therapeutics Valuation is Determined

Private company valuations like Halda Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.